Errigo A, Dore M, Portoghese M, Pes G
Nutrients. 2025; 17(5).
PMID: 40077635
PMC: 11901585.
DOI: 10.3390/nu17050765.
Jiang H, Liao Y, Zhu M, Jiramonai L, Wu H, Zhong Y
Research (Wash D C). 2025; 8:0617.
PMID: 40046514
PMC: 11881979.
DOI: 10.34133/research.0617.
Fracassi A, Qiao H, Lowell A, Cao J, Bode J, Masai H
ACS Pharmacol Transl Sci. 2025; 8(2):578-591.
PMID: 39974638
PMC: 11833727.
DOI: 10.1021/acsptsci.4c00667.
Yvan-Charvet L, Barouillet T, Borowczyk C
Nat Rev Cardiol. 2025; .
PMID: 39743562
DOI: 10.1038/s41569-024-01108-9.
Keever K, Askari B
Curr Res Pharmacol Drug Discov. 2024; 7:100203.
PMID: 39497763
PMC: 11532750.
DOI: 10.1016/j.crphar.2024.100203.
Nanoparticle-based itaconate treatment recapitulates low-cholesterol/low-fat diet-induced atherosclerotic plaque resolution.
Hong N, Chaplin A, Di L, Ravodina A, Bevan G, Gao H
Cell Rep. 2024; 43(11):114911.
PMID: 39466775
PMC: 11648168.
DOI: 10.1016/j.celrep.2024.114911.
A sexually dimorphic hepatic cycle of periportal VLDL generation and subsequent pericentral VLDLR-mediated re-uptake.
Martini T, Gobet C, Salati A, Blanc J, Mookhoek A, Reinehr M
Nat Commun. 2024; 15(1):8422.
PMID: 39341814
PMC: 11438914.
DOI: 10.1038/s41467-024-52751-2.
Investigating the Role of Cannabinoid Type 1 Receptors in Vascular Function and Remodeling in a Hypercholesterolemic Mouse Model with Low-Density Lipoprotein-Cannabinoid Type 1 Receptor Double Knockout Animals.
Vass Z, Shenker-Horvath K, Banyai B, Veto K, Torok V, Gem J
Int J Mol Sci. 2024; 25(17).
PMID: 39273484
PMC: 11395437.
DOI: 10.3390/ijms25179537.
GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms.
Mullur N, Morissette A, Morrow N, Mulvihill E
J Endocrinol. 2024; 263(1).
PMID: 39145614
PMC: 11466209.
DOI: 10.1530/JOE-24-0046.
Expression and Significance of Programmed Death-1 and Its Ligands in the Accelerated Formation of Atherosclerosis in an Induced Murine Lupus Model.
Yang Y, Chen Y, Li Y, Feng Y, Hu N, Xue L
Biomed Res Int. 2024; 2022:6255383.
PMID: 39050559
PMC: 11268968.
DOI: 10.1155/2022/6255383.
Insights from Murine Studies on the Site Specificity of Atherosclerosis.
Getz G, Reardon C
Int J Mol Sci. 2024; 25(12).
PMID: 38928086
PMC: 11204064.
DOI: 10.3390/ijms25126375.
Activation of Nrf2 inhibits atherosclerosis in ApoE mice through suppressing endothelial cell inflammation and lipid peroxidation.
He L, Chen Q, Wang L, Pu Y, Huang J, Cheng C
Redox Biol. 2024; 74:103229.
PMID: 38870781
PMC: 11247299.
DOI: 10.1016/j.redox.2024.103229.
Stromal cell-derived factor-1 alpha improves cardiac function in a novel diet-induced coronary atherosclerosis model, the SR-B1ΔCT/LDLR KO mouse.
Mullis D, Padilla-Lopez A, Wang H, Zhu Y, Elde S, Bonham S
Atherosclerosis. 2024; 395:117518.
PMID: 38627162
PMC: 11254567.
DOI: 10.1016/j.atherosclerosis.2024.117518.
Characterization of Atherosclerotic Mice Reveals a Sex-Dependent Susceptibility to Plaque Calcification but No Major Changes in the Lymphatics in the Arterial Wall.
Christ C, Ocskay Z, Kovacs G, Jakus Z
Int J Mol Sci. 2024; 25(7).
PMID: 38612867
PMC: 11012298.
DOI: 10.3390/ijms25074046.
Diet-Induced Severe Hyperhomocysteinemia Promotes Atherosclerosis Progression and Dysregulates the Plasma Metabolome in Apolipoprotein-E-Deficient Mice.
Andrews S, Koehle A, Paudel D, Neuberger T, Ross A, Singh V
Nutrients. 2024; 16(3).
PMID: 38337615
PMC: 10856797.
DOI: 10.3390/nu16030330.
Macrophage-based therapeutic approaches for cardiovascular diseases.
Sansonetti M, Al Soodi B, Thum T, Jung M
Basic Res Cardiol. 2024; 119(1):1-33.
PMID: 38170281
PMC: 10837257.
DOI: 10.1007/s00395-023-01027-9.
Synergistic Combinations of Gut- and Pancreas-Hormone-Based Therapies: Advancements in Treatments for Metabolic Diseases.
Lyons S, Beaudry J
Endocrinology. 2023; 164(11).
PMID: 37823483
PMC: 10612476.
DOI: 10.1210/endocr/bqad153.
Accelerated Extracellular Nucleotide Metabolism in Brain Microvascular Endothelial Cells in Experimental Hypercholesterolemia.
Czuba-Pakula E, Pelikant-Malecka I, Lietzau G, Wojcik S, Smolenski R, Kowianski P
Cell Mol Neurobiol. 2023; 43(8):4245-4259.
PMID: 37801200
PMC: 10661815.
DOI: 10.1007/s10571-023-01415-8.
Genetically-engineered hamster models: applications and perspective in dyslipidemia and atherosclerosis-related cardiovascular disease.
Liu G, Lai P, Guo J, Wang Y, Xian X
Med Rev (2021). 2023; 1(1):92-110.
PMID: 37724074
PMC: 10388752.
DOI: 10.1515/mr-2021-0004.
Effect of diet and genotype on the miRNome of mice with altered lipoprotein metabolism.
Busnelli M, Manzini S, Colombo A, Franchi E, Chiara M, Zaffaroni G
iScience. 2023; 26(9):107615.
PMID: 37664585
PMC: 10474470.
DOI: 10.1016/j.isci.2023.107615.